SEC Form 4 · accession 0000318306-18-000002
ABEONA THERAPEUTICS INC. · ABEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carsten Thiel
Officer — Chief Executive Officer
Period of report
Mar 29, 2018
Accepted (ET)
Apr 2, 2018 · 8:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000318306
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $13.65 | Mar 29, 2018 | A | 87,500 | A | Mar 29, 2019 | Mar 29, 2028 | Common stock | 87,500 | 87,500 | D |
| Stock option (right to buy)F1,F2 | $13.65 | Mar 29, 2018 | A | 262,500 | A | Apr 29, 2019 | Mar 29, 2028 | Common stock | 262,500 | 262,500 | D |
Explanation of responses
- F1100% accelerated vesting on change of control
- F2After twelve months from the Grant Date options vest 2.0833% monthly. All options vested 48 months from Grant Date.